These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gastric cancer: correlation between clinicopathological factors and survival of patients (III). Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762 [TBL] [Abstract][Full Text] [Related]
10. Outcome of hepatic resection for metastatic gastric cancer. Roh HR; Suh KS; Lee HJ; Yang HK; Choe KJ; Lee KU Am Surg; 2005 Feb; 71(2):95-9. PubMed ID: 16022005 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis. Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996 [TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer]. Ishida H; Fujioka M; Takeuchi I; Nakada H; Kondo K; Kishi T; Inokuma S; Suzuki T; Yamada H; Odaka A; Shimomura K; Murata N; Idezuki Y; Kamano T; Matsumoto Y; Miura T Gan To Kagaku Ryoho; 1999 Oct; 26(12):1690-3. PubMed ID: 10560372 [TBL] [Abstract][Full Text] [Related]
13. Impact of spleen preservation in patients with gastric cancer. Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial. Kono K; Takahashi A; Ichihara F; Amemiya H; Iizuka H; Fujii H; Sekikawa T; Matsumoto Y Clin Cancer Res; 2002 Jun; 8(6):1767-71. PubMed ID: 12060615 [TBL] [Abstract][Full Text] [Related]
15. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596 [TBL] [Abstract][Full Text] [Related]
16. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847 [TBL] [Abstract][Full Text] [Related]
17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
18. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Martin RC; Edwards MJ; McMasters KM Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202 [TBL] [Abstract][Full Text] [Related]
20. Is bursectomy necessary for patients with gastric cancer invading the serosa? Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]